Description: This article describes the primary goal of the Actuarial Research Clearing House [ARCH], its editorial policy and the procedure for submitting manuscripts. From Actuarial Research Clearing House 1992, Vol. 2.

Description: This article describes the primary goal of the Actuarial Research Clearing House [ARCH], its editorial policy and the procedure for submitting manuscripts. From Actuarial Research Clearing House 1991, Vol. 3.

Description: A personal reflection and anecdote on a quote by Carl Jung. "Until you make the unconscious conscious, it will direct your life and you will call it fate."

Description: This article describes the primary goal of the Actuarial Research Clearing House [ARCH], its editorial policy and the proicedure for submitting manuscripts. From Actuarial Research Clearing House, 1991 Vol. 2.

Description: During 2005 the Actuary of the Future Section Council reviewed its plans and strategies for 2006. During its discussions, the council reaffirmed the section’s mission “to identify and promote new opportunities, skills and new ways of thinking to help actuaries excel on their career journeys” and established this as the primary section goal for 2006 to increase membership value.

Description: United States actuaries have traditionally focused their attention on the liability side of pension fund balance sheets. However, with the private pension system now one of the largest sources of national capital, there is an opportunity for actuaries to establish themselves as primary sources of investment-related information and advice.

Description: The author discusses how small firms can compete successfully against big firms by cre¬ating a micro-niche business, because other firms—including big firms—cannot compete directly. In this way a small firm can compete against large firms with great success by stepping outside direct competi¬tion, in which it cannot hope to win. From ‘The Stepping Stone’ issue number 43.

Description: Recently, actuaries have become more involved in formulary decisions due to high and variable pharmacy cost and utilization trends. How can actuaries and pharmaceutical manufacturers work together to better predict the market while covering key drugs? What discussions are currently taking place between manufacturers and payers? Is there value in these discussions that actuaries are missing? This presentation will provide both actuarial and manufacturer perspectives in order to create a mutual understanding that will begin to direct future conversations to benefit both stakeholders.

Description: A Discussion of why female mortality is higher than male mortality at higher ages.

Description: Department column featuring an interview with Sim Segal.